This list is an analysis based on recent market events. It's not an investment recommendation.
About
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was founded in 1989 and is headquartered in Nassau, the Bahamas.
The current price of NYMXF is $0.05 USD — it has decreased by -9.09% in the past 24 hours. Watch Nymox Pharmaceutical stock price performance more closely on the chart.
What is Nymox Pharmaceutical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Nymox Pharmaceutical stocks are traded under the ticker NYMXF.
Is Nymox Pharmaceutical stock price growing?▼
NYMXF stock has fallen by -18.03% compared to the previous week, the month change is a -9.26% fall, over the last year Nymox Pharmaceutical has showed a -54.55% decrease.
What is Nymox Pharmaceutical market cap?▼
Today Nymox Pharmaceutical has the market capitalization of 4.73M
What is Nymox Pharmaceutical revenue for the last year?▼
Nymox Pharmaceutical revenue for the last year amounts to 0 USD.
What is Nymox Pharmaceutical net income for the last year?▼
NYMXF net income for the last year is -17.69M USD.
How many employees does Nymox Pharmaceutical have?▼
As of April 16, 2026, the company has 16 employees.
In which sector is Nymox Pharmaceutical located?▼
Nymox Pharmaceutical operates in the Health & Wellness sector.
When did Nymox Pharmaceutical complete a stock split?▼
Nymox Pharmaceutical has not had any recent stock splits.
Where is Nymox Pharmaceutical headquartered?▼
Nymox Pharmaceutical is headquartered in Nassau, Canada.